The Insulin Resistance Intervention after Stroke trial: a perspective on future practice and research
The prevention of recurrent events after ischaemic stroke and transient ischaemic attack is well established and based on lifestyle changes, antithrombotics, statins, antihypertensives and carotid surgery. The international IRIS trial assessed whether pioglitazone, a glucose-lowering insulin-sensiti...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Published: |
SAGE Publications
2016
|
| Subjects: | |
| Online Access: | https://eprints.nottingham.ac.uk/35498/ |